RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CK Life Sciences Intl (Holdings) - Stock

CK Life Sciences Intl (Holdings) Equity 2024

CK Life Sciences Intl (Holdings) Equity

4.19 B HKD

Ticker

775.HK

ISIN

KYG2176J1058

WKN

662762

In 2024, CK Life Sciences Intl (Holdings)'s equity was 4.19 B HKD, a 0.75% increase from the 4.16 B HKD equity in the previous year.

CK Life Sciences Intl (Holdings) Aktienanalyse

What does CK Life Sciences Intl (Holdings) do?

CK Life Sciences International (Holdings) Inc (CKLS) is a leading company in the field of life sciences and biotechnology, founded in Hong Kong in 1994. It is a subsidiary of CK Hutchison Holdings, one of the largest conglomerates in Asia. CKLS operates in the business sectors of agricultural sciences, health sciences, and investment. The company has international offices in Australia, the USA, Canada, China, and Europe. The agricultural sciences division of CKLS focuses on research and development of plant-based technologies, including plant breeding, agricultural production, and biological pest control. CKLS specifically engages in the development of breeding techniques that enhance the speed, efficiency, and precision of plant breeding. The goal is to increase agricultural production and reduce the ecological footprint. CKLS also has its own brand of biological plant protection products called ABOUND, which provides protection against pests and diseases. The health sciences division of CKLS encompasses research and development of pharmaceuticals and dietary supplements. The company specializes in the development of dietary supplements made from natural ingredients that are intended to promote health and well-being. An example is the probiotic BioGaia, which is used to support digestive health and treat diarrhea. CKLS also engages in the research of herbal medicine and traditional Chinese medicine. The company has launched its own product line of traditional Chinese medicine, developed based on the millennia-old healing methods of Chinese medicine. The investment division of CKLS focuses on investing in companies and innovations that aim to improve life. For example, CKLS has invested in the US company StemCells, which specializes in the research and development of stem cell transplantation for neurological disorders. Overall, CKLS offers a wide range of products and services aimed at improving people's lives and health. Based on its research and development activities in the biotech industry, the company is working to solidify its leading role in the field of life sciences and biotechnology. In summary, CKLS is a leading company in the field of life sciences and biotechnology, operating in the sectors of agricultural sciences, health sciences, and investment. The company offers a wide range of products and services aimed at improving people's lives and health. CK Life Sciences Intl (Holdings) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing CK Life Sciences Intl (Holdings)'s Equity

CK Life Sciences Intl (Holdings)'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding CK Life Sciences Intl (Holdings)'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating CK Life Sciences Intl (Holdings)'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

CK Life Sciences Intl (Holdings)'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in CK Life Sciences Intl (Holdings)’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about CK Life Sciences Intl (Holdings) Stock

What is the equity of CK Life Sciences Intl (Holdings) this year?

CK Life Sciences Intl (Holdings) has equity of 4.19 B HKD this year.

What was the equity of CK Life Sciences Intl (Holdings) compared to the previous year?

The equity of CK Life Sciences Intl (Holdings) has increased/decreased by 0.75% increased compared to the previous year.

What impact does a high equity have on investors of CK Life Sciences Intl (Holdings)?

A high equity is advantageous for investors of CK Life Sciences Intl (Holdings) as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of CK Life Sciences Intl (Holdings)?

A low equity can be a risk for investors of CK Life Sciences Intl (Holdings), as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of CK Life Sciences Intl (Holdings) affect the company?

An increase in equity of CK Life Sciences Intl (Holdings) can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of CK Life Sciences Intl (Holdings) affect the company?

A reduction in equity of CK Life Sciences Intl (Holdings) can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of CK Life Sciences Intl (Holdings)?

Some factors that can affect the equity of CK Life Sciences Intl (Holdings) include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of CK Life Sciences Intl (Holdings) so important for investors?

The equity of CK Life Sciences Intl (Holdings) is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can CK Life Sciences Intl (Holdings) take to change the equity?

To change equity, CK Life Sciences Intl (Holdings) can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does CK Life Sciences Intl (Holdings) pay?

Over the past 12 months, CK Life Sciences Intl (Holdings) paid a dividend of 0.01 HKD . This corresponds to a dividend yield of about 2.42 %. For the coming 12 months, CK Life Sciences Intl (Holdings) is expected to pay a dividend of 0.01 HKD.

What is the dividend yield of CK Life Sciences Intl (Holdings)?

The current dividend yield of CK Life Sciences Intl (Holdings) is 2.42 %.

When does CK Life Sciences Intl (Holdings) pay dividends?

CK Life Sciences Intl (Holdings) pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of CK Life Sciences Intl (Holdings)?

CK Life Sciences Intl (Holdings) paid dividends every year for the past 13 years.

What is the dividend of CK Life Sciences Intl (Holdings)?

For the upcoming 12 months, dividends amounting to 0.01 HKD are expected. This corresponds to a dividend yield of 2.42 %.

In which sector is CK Life Sciences Intl (Holdings) located?

CK Life Sciences Intl (Holdings) is assigned to the 'Health' sector.

Wann musste ich die Aktien von CK Life Sciences Intl (Holdings) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CK Life Sciences Intl (Holdings) from 6/5/2023 amounting to 0.008 HKD, you needed to have the stock in your portfolio before the ex-date on 5/23/2023.

When did CK Life Sciences Intl (Holdings) pay the last dividend?

The last dividend was paid out on 6/5/2023.

What was the dividend of CK Life Sciences Intl (Holdings) in the year 2023?

In the year 2023, CK Life Sciences Intl (Holdings) distributed 0.01 HKD as dividends.

In which currency does CK Life Sciences Intl (Holdings) pay out the dividend?

The dividends of CK Life Sciences Intl (Holdings) are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CK Life Sciences Intl (Holdings)

Our stock analysis for CK Life Sciences Intl (Holdings) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CK Life Sciences Intl (Holdings) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.